$SIBN

Maheshwari Anshul sold $56K of SIBN

Maheshwari Anshul (Chief Financial Officer) sold 3,317 shares of SI-BONE, Inc. (SIBN) at an average of $16.77 ($16.73–$16.80) across 2 trades on 2026-07-02.

Original reporting
SEC EDGAR · Maheshwari Anshul
Published Jul 6, 2026, 9:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SIBN
Neutral
high confidence
Mentioned
$SIBN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SIBNNeutralLow
01

Why it matters

The newest information is the CFO’s open-market sale details (date, shares, price range, and post-transaction holdings).

02

Market read

Traders may monitor insider activity as a sentiment datapoint, but the filing alone does not provide a fundamental catalyst.

03

What to watch

The text notes no pre-arranged 10b5-1 plan, which can raise scrutiny, but the article provides no context on prior grants, tax obligations, or total insider compensation.

Relevance 3/10Novelty 5/10Timing: after-hours/filing update (Form 4 filed 2026-07-06)

Background

The article is a SEC Form 4 insider transaction disclosure for SI-BONE, Inc. (SIBN).

Company-level read

Ticker impact

$SIBNNeutralHigh confidence
Context

SI-BONE CFO Maheshwari Anshul sold 3,317 shares in open-market transactions at ~$16.77, per a newly filed Form 4.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a disclosed open-market sale with no 10b5-1 plan and no accompanying fundamental update in the text, making it more of a positioning datapoint than a catalyst.

Market effects

No sector-wide implications disclosed; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or scheduled liquidity needs rather than bearish fundamentals—especially when the transaction size is modest relative to typical insider holdings.

Key entities

  • SI-BONE, Inc.

    Company whose CFO insider sale is disclosed via Form 4.

  • Maheshwari Anshul

    Chief Financial Officer who sold 3,317 shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to t